2015
DOI: 10.1016/j.mri.2015.08.007
|View full text |Cite
|
Sign up to set email alerts
|

Detectability and anatomical correlation of middle ear cholesteatoma using fused thin slice non-echo planar imaging diffusion-weighted image and magnetic resonance cisternography (FTS-nEPID)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(4 citation statements)
references
References 21 publications
0
4
0
Order By: Relevance
“…The fusion of DWI and HRCT images has been reported in previous studies [8][9][10][11][12] in which cholesteatoma lesions with high signal intensity on DWI were superimposed on the corresponding HRCT temporal bone structures to improve preoperative cholesteatoma detection, assessment, and localization; however, DWI and HRCT are 2 different imaging techniques, and the fusion process is cumbersome. Kanoto et al 13 and Watanabe et al 14 showed that DWI with MR cisternography can increase the accuracy of anatomic localization. However, MR cisternography sequences of the ear require additional scanning time, which may cause motion artifacts due to patient discomfort from the prolonged body position, leading to image-quality degradation.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The fusion of DWI and HRCT images has been reported in previous studies [8][9][10][11][12] in which cholesteatoma lesions with high signal intensity on DWI were superimposed on the corresponding HRCT temporal bone structures to improve preoperative cholesteatoma detection, assessment, and localization; however, DWI and HRCT are 2 different imaging techniques, and the fusion process is cumbersome. Kanoto et al 13 and Watanabe et al 14 showed that DWI with MR cisternography can increase the accuracy of anatomic localization. However, MR cisternography sequences of the ear require additional scanning time, which may cause motion artifacts due to patient discomfort from the prolonged body position, leading to image-quality degradation.…”
Section: Resultsmentioning
confidence: 99%
“…Patients with a subjective score of ,3 for both fused images were excluded from further localization diagnosis. In this study, 4 anatomic regions of the middle ear (attic, tympanic cavity, mastoid antrum, and mastoid cavity) were used for localization as proposed by Kanoto et al: 13 1) attic: superior to the horizontal semicircular canal and anterior to the posterior margin of the horizontal semicircular canal; 2) the tympanic cavity: inferior to the horizontal semicircular canal and anterior to the posterior margin of the horizontal semicircular canal; 3) the mastoid antrum: superior to the horizontal semicircular canal and posterior to the posterior border of the horizontal semicircular canal; and 4) mastoid cells: inferior to the horizontal semicircular canal and posterior to the posterior border of the horizontal semicircular canal.…”
Section: Evaluation Of Efficacy In Cholesteatoma Localizationmentioning
confidence: 99%
“…DWI may also replace delayed gadolinium-enhanced T1w sequences [60]. Images from non-EPI sequences or newer EPI techniques such as RESOLVE can even be fused with anatomical images (T1w and T2w) in coronal and/or axial orientation to better localize suspected lesions [63,64]. This also helps to differentiate e. g. the characteristic T1 hyperintensity of cholesterol granuloma, or asymmetric apex fat, and opacified/infected petrous apex [65].…”
Section: Diffusion-weighted Imaging (Epi-dwi Non-epi-dwi Resolve)mentioning
confidence: 99%
“…Doctors often construct preoperative health education for patients and apply recovery technology in the perioperative period to reduce the operative stress response and enhance the postoperative recover treatment effect. 5,6 Research on FTS was first carried out in cardiac surgery in Europe and America. At present, the FTS concept has been successfully applied for treating colorectal cancer, esophageal cancer, stomach cancer, and thyroid surgery.…”
Section: Introductionmentioning
confidence: 99%